Ciotti, Silvia and Micheli, Mary and Cometa, Antonella and De Carlo, Claudia and Martini, Giancarlo (2021) Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health. European Journal of Case Reports in Internal Medicine, 8 (Sup 2). pp. 3-8. ISSN 2284-2594
|
Text
Treatment with Delta-9.pdf - Published Version Download (450kB) | Preview |
Abstract
Multiple sclerosis (MS) is the most common cause of non-traumatic neurological disability in young adults. It has effects at different levels: physical, emotional, psychological, cognitive and social, with a great variety of signs and symptoms. In particular, spasticity contributes to reducing the motor performance of patients with MS, causing pain, reduction in distance walked and limitations in social life. We present the case of a 39-year-old woman with MS. She was treated with delta-9-tetrahydrocannabinol/cannabidiol and the outcome was assessed with the International Classification of Functioning Disability and Health core set framework.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Multiple sclerosis, ICF, neurorehabilitation, delta-9-tetrahydrocannabinol/cannabidiol |
Subjects: | 600 Tecnologia - Scienze applicate 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale) |
Depositing User: | Marina Spanti |
Date Deposited: | 01 Feb 2022 10:10 |
Last Modified: | 01 Feb 2022 10:10 |
URI: | http://eprints.bice.rm.cnr.it/id/eprint/21469 |
Actions (login required)
View Item |